CLOV vs GYRO · rev $1.37B vs P/E 46, rev $1.8M
Clover Health Investments Corp (CLOV) versus Gyrodyne Company of America Inc (GYRO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Gyrodyne Company of America Inc (GYRO) is a real estate services company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported GYRO revenue for 2015-08-31 was $1.8M. Net income was -$2.5M. Revenue was down 34.8% from 2014-12-31 to 2015-08-31. GYRO currently screens at market cap $20.0M and trailing P/E 45.5.
CLOV currently screens at market cap $1.55B. GYRO currently screens at market cap $20.0M and trailing P/E 45.5.
Not investment advice. Open the CLOV and GYRO stock pages for the full models.
Not investment advice.